HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.

AuthorsElsa Lestang, Aurelie Caristan, Antoine Néel, Julie Graveleau, Elisabeth Duhamel, Agathe Masseau, Jerome Connault, Hervè Maisonneuve, Steven Le Gouill, Nicolas Blin, Cyrille Touzeau, Philippe Moreau, Mohamed Hamidou
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 56 Issue 6 Pg. 1895-6 (Jun 2015) ISSN: 1029-2403 [Electronic] United States
PMID25347429 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Glucocorticoids
  • Vascular Endothelial Growth Factor A
  • Thalidomide
  • Dexamethasone
  • Lenalidomide
Topics
  • Aged
  • Angiogenesis Inhibitors (therapeutic use)
  • Dexamethasone (therapeutic use)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids (therapeutic use)
  • Humans
  • Lenalidomide
  • Male
  • Middle Aged
  • POEMS Syndrome (blood, drug therapy, pathology)
  • Recurrence
  • Remission Induction
  • Retrospective Studies
  • Thalidomide (analogs & derivatives, therapeutic use)
  • Time Factors
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: